Bellicum Pharmaceuticals, Inc.
PSCA CAR-T CELLS
Last updated:
Abstract:
The technology relates generally to the field of immunology and relates in part to T cell compositions and methods for treating diseases and disorders associated with the presence of tumor cells that express prostate stem cell antigen.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2019
Issue date:
3 Mar 2022